查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790294

關節內粘稠補充療法市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場預測，2025 年至 2033 年

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three & Five Injections), By End Use (Hospitals & Orthopedic Clinics/ASCs), By Region (North America, Europe, APAC, LATAM & MEA), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 118 Pages | 商品交期: 2-10個工作天內

價格

關節內粘稠補充療法市場摘要

2024 年全球關節內粘稠補充療法市場價值估計為 53 億美元，預計到 2033 年將達到 93.9 億美元，2025 年至 2033 年的複合年成長率為 6.21%。關節內粘稠補充療法旨在緩解關節疼痛和改善膝關節功能。

骨關節炎盛行率的不斷上昇在推動關節內粘稠補充療法的需求方面起著關鍵作用。骨關節炎是一種慢性退化性關節疾病，也是造成永久性殘疾的主要原因。骨關節炎通常在 30 歲以後發病，並在診斷後 10 年內發展為致殘狀態。 2025 年 3 月發表在《科學報告》上的一篇論文分析了 2021 年全球疾病負擔研究的骨關節炎數據。研究報告顯示，全球骨關節炎盛行率已從 1990 年的 2,090 萬例飆升至 2021 年的 4,660 萬例，殘障壽命年數顯著增加。該研究還強調了日益擴大的健康差距，女性、SDI 高的國家以及亞洲等地區的負擔更重。

關節疾病發生率的上升是關節內粘稠補充療法市場的主要驅動力。由於人口老化和久坐不動的生活方式，退化性疾病變得越來越普遍。這導致對緩解症狀的非手術治療方法的需求增加。關節內粘稠補充療法透過改善關節潤滑和活動性來解決這個問題。醫療保健系統正在認知到推遲手術干預的成本效益。 2024年11月發表在《骨關節炎與軟骨》雜誌上的一篇論文強調，2020年骨關節炎影響了全球7.6%的人口，過去30年來患病率成長了132.2%。此外，論文指出，早發性骨關節炎病例（發生在55歲之前）佔新診斷病例的一半以上，佔所有傷殘年數的26.1%。

對微創治療的偏好促進了市場成長。越來越多的患者和醫療保健提供者選擇恢復時間更短、併發症更少的治療方法。關節內粘稠補充療法滿足了這些需求，推動了它在常規臨床實踐中的應用。配方開發的進步也促進了它的廣泛應用。現在可以使用單次和多次注射方案來滿足各種患者情況。 2024 年 4 月發表在《Cureus》雜誌上的一項研究使用 2019 年至 2022 年的 BRFSS 數據分析了美國成年人的關節炎趨勢。結果強調了盛行率上升以及不同人口統計和健康狀況之間的差異。這些見解支持擴大採用微創手術 (MIS) 治療關節炎，旨在減輕疼痛、併發症和恢復時間。

醫療保健提供者意識的提升和報銷政策的簡化進一步推動了市場的成長。持續的臨床檢驗使關節內粘稠補充療法被廣泛接受為標準治療方案，並促進了其在關節退化早期階段的應用。市場參與者正在擴大其產品陣容，以滿足日益成長的臨床需求。區域監管機構的支持正在促進產品在關鍵市場的供應。 2024年1月，工業工業株式會社宣布與Anika Therapeutics及其他兩家製造商合作，利用新型交聯透明質酸技術增強多次注射關節內粘稠補充療法產品。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章關節內粘稠補充療法市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 關節內粘稠補充療法：市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析

第4章。關節內粘稠補充療法市場細分分析（按產品），2021-2033 年

  • 定義和範圍
  • 2024 年及 2033 年各產品市場佔有率分析
  • 細分儀表板
  • 2021 年至 2033 年全球關節內粘稠補充療法市場（按產品分類）
  • 1次注射
    • 市場估計與預測（2021-2033）
  • 3次注射
    • 市場估計與預測（2021-2033）
  • 5次注射
    • 市場估計與預測（2021-2033）

第5章。關節內粘稠補充療法市場細分分析（按最終用途），2021-2033 年

  • 定義和範圍
  • 細分儀表板
  • 全球關節內粘稠補充療法市場（按最終用途分類），2021 年至 2033 年
  • 醫院
    • 市場估計與預測（2021-2033）
  • 整形外科診所/ASC
    • 市場估計與預測（2021-2033）

第6章。 2021-2033 年關節內粘稠補充療法市場細分分析（按地區）

  • 2024 年及 2033 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概況
  • 2024 年和 2033 年關節內粘稠補充療法市場佔有率（按地區分類）：
  • 北美洲
    • 北美關節內粘稠補充療法市場，2021-2033
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033 年歐洲關節內粘稠補充療法市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司簡介
  • 2024年熱圖分析
  • 公司簡介
    • DePuy Synthes
    • Fidia Farmaceutici SpA
    • Sanofi
    • Anika Therapeutics, Inc.
    • SEIKAGAKU CORPORATION
    • Zimmer Biomet
    • Smith &Nephew PLC
    • Ferring Pharmaceutical BV
    • Lifecore Biomedical, LLC（Landec）
    • LG Life Sciences Ltd.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-1-68038-982-1

Viscosupplementation Market Summary

The global viscosupplementation market size was estimated at USD 5.30 billion in 2024 and is projected to reach USD 9.39 billion by 2033, growing at a CAGR of 6.21% from 2025 to 2033. Viscosupplementation aims to alleviate joint pain and enhance the functional state of the knee.

The growing incidence of osteoarthritis plays a significant role in driving the demand for viscosupplementation. Osteoarthritis, a chronic degenerative joint disease, is the primary cause of enduring disability. It typically emerges after the age of 30 and can progress to a disabling condition within a decade of diagnosis. In March 2025, an article published in Scientific Reports analyzed osteoarthritis data from the Global Burden of Disease Study 2021. The study reported a sharp rise in global OA incidence from 20.9 million cases in 1990 to 46.6 million in 2021, with a notable increase in years lived with disability. It also highlighted growing health inequalities, with a higher burden seen among women, in high SDI countries, and regions like Asia.

The rising incidence of joint disorders is a key driver of the viscosupplementation market. Degenerative conditions are becoming more common due to aging populations and sedentary lifestyles. This is leading to greater demand for non-surgical treatment approaches that provide symptom relief. Viscosupplementation addresses this by improving joint lubrication and mobility. Healthcare systems are recognizing the cost-effectiveness of delaying surgical intervention. In November 2024, an article in Osteoarthritis and Cartilage highlighted that osteoarthritis affected 7.6% of the global population in 2020, with prevalence increasing by 132.2% over the past 30 years. Moreover, it is noted that early-onset OA cases, occurring before age 55, accounted for over half of new diagnoses and 26.1% of total YLDs.

Preference for minimally invasive treatment options is contributing to market expansion. Patients and providers are increasingly opting for procedures that offer reduced recovery time and fewer complications. Viscosupplementation aligns with these needs, supporting its adoption in routine clinical practice. Ongoing developments in formulation are also influencing uptake. Single and multiple-injection regimens are now available to accommodate different patient profiles. In April 2024, a study published in Cureus analyzed arthritis trends among U.S. adults using BRFSS data from 2019 to 2022. The findings underscored rising prevalence and disparities by demographics and health status. These insights support growing adoption of minimally invasive surgeries (MIS) for arthritis, aimed at reducing pain, complications, and recovery time.

Growing awareness among healthcare providers and structured reimbursement policies are further supporting market growth. Continued clinical validation has led to broader acceptance of viscosupplementation in standard care protocols. This is encouraging its use at earlier stages of joint degeneration. Market players are responding with expanded product offerings to meet rising clinical demand. Regional regulatory support has facilitated product availability across key markets. In January 2024, Seikagaku Corporation announced collaborations with Anika Therapeutics and two other manufacturers to enhance multi-injection viscosupplementation products using novel cross-linked hyaluronic acid technologies.

Global Viscosupplementation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global viscosupplementation market report based on product, end use, and region:

  • Product Outlook (Revenue in USD Billion, 2021 - 2033)
  • Single Injection
  • Three Injection
  • Five Injection
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Orthopedic Clinics/ASCs
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Viscosupplementation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of osteoarthritis among aging populations
      • 3.2.1.2. Rising demand for non-surgical pain management options in orthopedics
      • 3.2.1.3. Advancements in hyaluronic acid formulations improving product efficacy
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment limiting access in low- and middle-income countries
      • 3.2.2.2. Limited long-term effectiveness leading to physician skepticism and guideline restrictions
  • 3.3. Viscosupplementation: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis

Chapter 4. Viscosupplementation Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global viscosupplementation market, by product, 2021 to 2033
  • 4.5. Single injection
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Three injection
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Five injection
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Viscosupplementation Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Segment Dashboard
  • 5.3. Global viscosupplementation market, by End Use, 2021 to 2033
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Orthopedic Clinic/ASCs
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Viscosupplementation Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Viscosupplementation Market Share by Region, 2024 & 2033:
  • 6.5. North America
    • 6.5.1. North America viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.S. viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Canada viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. UK viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Germany viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. France viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Italy viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Spain viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Norway viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Framework
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Sweden viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Framework
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Denmark viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Framework
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Japan viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. China viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. India viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Australia viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Framework
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. South Korea viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Regulatory Framework
      • 6.7.6.3. Competitive Scenario
      • 6.7.6.4. Thailand viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Framework
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Brazil viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Framework
      • 6.9.1.3. Competitive Scenario
      • 6.9.1.4. South Africa viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Framework
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Saudi Arabia viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Framework
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. UAE viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Framework
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Kuwait viscosupplementation market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
  • 7.4. Heatmap Analysis, 2024
  • 7.5. Company Profile
    • 7.5.1. DePuy Synthes
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Fidia Farmaceutici S.p.A
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Sanofi
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Anika Therapeutics, Inc.
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. SEIKAGAKU CORPORATION
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Zimmer Biomet
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Smith & Nephew PLC
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Ferring Pharmaceutical B.V.
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Lifecore Biomedical, LLC (Landec)
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. LG Life Sciences Ltd.
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. F. Hoffmann-La Roche Ltd.
      • 7.5.11.1. Company Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 10 Mexico Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 11 Europe Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 12 Europe Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 13 UK Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 14 UK Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 15 Germany Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 16 Germany Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 17 France Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 18 France Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 19 Italy Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 20 Italy Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 21 Spain Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 22 Spain Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 23 Sweden Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 24 Sweden Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 25 Denmark Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 26 Denmark Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 27 Norway Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 28 Norway Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 31 Japan Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 32 Japan Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 33 China Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 34 China Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 India Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 36 India Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 37 Australia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 38 Australia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 40 South Korea Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 41 Thailand Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 44 Latin America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 45 Brazil Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 46 Brazil Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Argentina Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 48 Argentina Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 49 MEA Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 50 MEA Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 51 South Africa Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 52 South Africa Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 53 Saudi Arabia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 54 Saudi Arabia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 55 UAE Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 56 UAE Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 57 Kuwait Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 58 Kuwait Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Viscosupplementation market: outlook
  • Fig. 8 Viscosupplementation competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Viscosupplementation market driver impact
  • Fig. 11 Viscosupplementation market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Viscosupplementation market: Product movement analysis
  • Fig. 15 Viscosupplementation market: Product outlook and key takeaways
  • Fig. 16 Single injection market estimates and forecast, 2021 - 2033
  • Fig. 17 Five injection market estimates and forecast, 2021 - 2033
  • Fig. 18 Toe intramedullary implants market estimates and forecast, 2021 - 2033
  • Fig. 19 Three injection market estimates and forecast, 2021 - 2033
  • Fig. 20 Scaphoid bone implants market estimates and forecast, 2021 - 2033
  • Fig. 21 Viscosupplementation market: End Use movement analysis
  • Fig. 22 Viscosupplementation market: End Use outlook and key takeaways
  • Fig. 23 Orthopedic Clinic/ASCs market estimates and forecasts, 2021 - 2033
  • Fig. 24 Hospitals market estimates and forecasts,2021 - 2033
  • Fig. 25 Global viscosupplementation market: Regional movement analysis
  • Fig. 26 Global viscosupplementation market: Regional outlook and key takeaways
  • Fig. 27 North America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 U.S. viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Canada viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Mexico viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 UK viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Spain viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Norway viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Japan viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 China viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 India viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Australia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 South Korea viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Thailand viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Brazil viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Argentina viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 MEA viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Africa viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Saudi Arabia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 UAE viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Kuwait viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key company categorization
  • Fig. 79 Heat map analysis, 2024